Items of recent pandemic news: A resource for finding authorized therapeutics in the US; how long booster shots protect; an early study isolating ultrapotent antibodies from elite neutralizers; and a new variant on the Omicron variant. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: A common cold coronavirus may have mixed into Omicron; AstraZeneca’s long-lasting injectable antibody gets authorized; SARS-CoV-2 can infect fat cells; what we tentatively know about Omicron; and much more. Plus a frippery. Quotes of the … Continue reading →
Items of recent pandemic news: Survivors of severe Covid have double the odds of dying, from all causes, within a year; Minnesota’s fading Delta surge; where the Omicron variant may have come from; and more. Plus a frippery. Omicron update … Continue reading →
Items of recent pandemic news: CureVac’s second-generation vaccine does as well as Pfizer / BioNTech’s in a pre-clinical trial; the brain may participate directly in immune memory; and approval for boosters for all US adults. Plus a frippery. Boosters for … Continue reading →
Items of recent pandemic news: Vaccination halves chances of long Covid; the role of auto-antibodies in severe disease; rising out-of-pocket costs of Covid; the unlikelihood that September 20 will see booster shots; and more. Plus a frippery. 1. Boosters will … Continue reading →
Items of recent pandemic news: Saliva tests may not be sensitive enough for the asymptomatic; early antiviral promise for a cholesterol-lowering drug; booster shots coming to the immunocompromised and then to all US citizens; and more. Plus a frippery. 1. … Continue reading →
Items of recent pandemic news you may have missed: Moderna kids’ trial is enrolling; a new variant seen in Polish mink; a rapid-testing approach to in-person schooling; the tidal wave of vaccine mandates; and more. Plus a frippery. 1. Vaccination … Continue reading →
Items of recent pandemic news you may have missed: Too much testing of asymptomatic immune people? The new risk calculus of the delta variant, the coming mitigations, the anatomy of why delta spreads so fast, and more. Plus a frippery. … Continue reading →
Nine items of recent pandemic news you may have missed: Rapid testing, mixing and matching vaccines, booster shots, the genetics predicting severe Covid-19, another blow to J&J, some mechanisms behind neurological damage, and more. Plus a frippery. 1. Pfizer wants … Continue reading →
Three items of recent pandemic news: Human trials near for an inhalable antiviral; rumors of bad behavior by Google with an infection-tracking and notification app; and the WHO recommends against vaccinating children. Plus a news brief and a frippery. WHO … Continue reading →
Two items of recent pandemic news: Studies point to long-lasting, possibly lifelong immunity from natural infection; and rapid developments in the highly political question of where SARS-CoV-2 came from. Plus news briefs and a pair of fripperies. Origin, again It … Continue reading →
Three items of recent pandemic news: Pfizer’s vaccine can keep for 30 days at refrigerator temperatures; neutralizing antibody levels emerge as a correlate of protection; and the long stretch of post-trauma grief that awaits us. Plus news briefs and a … Continue reading →
Two items of recent pandemic news: Sanofi & GSK get some good news from a Phase II study of their reformulated vaccine candidate; and questions swirl anew around the origins of the pandemic virus. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: A tapeworm remedy to fight Covid; you can stop sanitizing now; and a new concern about blood clots with the Johnson & Johnson vaccine. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
